Get Started

EVGN

NASD Evogene Ltd
Nov 4, 2026 · 9:57 PM ET EOD Market Closed

$0.3568 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.3568, $0.0074 below the day’s high of $0.3642

YTD change
-67.56%
vs 20-day SMA
-5.70%
vs 200-day SMA
-45.69%

Price ranges

Previous day
$0.3524 $0.3898
open $0.3608 close $0.3599
-$0.0009 (-0.25%)
Today
$0.3503 $0.3642
open $0.3503 now $0.3568
+$0.0065 (+1.86%)
Past week
$0.3524 $0.3898
from $0.3638 now $0.3568
-$0.0070 (-1.92%)
Past month
$0.3452 $0.4290
from $0.4237 now $0.3568
-$0.0669 (-15.79%)
This year
$0.3452 $1.2400
from $1.1000 now $0.3568
-$0.7432 (-67.56%)

Price & Performance

-0.40 (-52.55%) / 6M

$0.3220$0.4901$0.6581$0.8262May 4Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.7% away from all-time highs of $102.3860
  • EVGN is down 68% since the beginning of the year
  • EVGN is down 71% over the past 12 months
  • EVGN is down 16% over the past 1 month
  • 0% of all EVGN investors are betting against EVGN

EVGN reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -70.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.14
Earnings momentum +26.3% Quarterly EPS growth
Quarterly change +26.3%

Valuation

P/E ratio N/A
Enterprise value $6.2M
Beta 1.80

Balance sheet & scale

IncomeN/A
Revenue$1.3M
Cash$9.4M
Debt$2.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $6.4M

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $478.48 +3.73%
MRNA Moderna, Inc. $258.38 +13.11%
RVMD Revolution Medicines, Inc. $199.70 +2.82%
ROIV Roivant Sciences Ltd. $38.23 +6.08%
BNTX BioNTech SE Sponsored ADR $90.70 +4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.